1/18/2013

Amgen plans to invest about $200 million to construct a manufacturing plant at the Tuas Biomedical Park in Singapore. Work on the facility, Amgen's first in Asia, is expected to start within months. The plant's first products will be antibody drugs.

Full Story:
Reuters

Related Summaries